Biotechnology

News

Closing The Gap

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Virtual Event

Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Numaferm GmbH

Jennewein Biotechnologie GmbH

KPMG

Dechema e.V.

BCNP Consultants GmbH

International Sustainable Chemistry Collaborative Centre ISC3

Henkel AG & Co. KGaA

SchüllerConsulting

Fujifilm

Germany Trade & Invest

Dottikon Exclusive Synthesis AG

Farmindustria

Thomson Reuters

Novozymes Biopharma UK Ltd.

Kaye Scholer

Medera

European Circular Bioeconomy Fund (ECBF)

AstraZeneca

Symeres

Bayer AG

Bachem

Reverdia

Berlin Partner für Wirtschaft und Technologie GmbH

WuXi AppTec

ACIB Austrian Centre of Industrial Biotechnology

Managm. Consult. Chemicals

Beckman Coulter, Inc.

Inseit AG

Federchimica

Bio4Business

Groupe Novasep

Rentschler Biopharma SE

BioLizard

Arthur D. Little

Miebach Consulting GmbH

Siegfried

Sartorius AG

Solvay

Jan Ramakers Fine Chemical

Alira Health S.r.l.

CzechInvest

Hamilton Bonaduz AG

Millipore Corporation

Tufts University

Olon S.p.A.

KPMG

Messe München GmbH

AFYREN SAS

Evonik Industries AG

Ontario Int. Marketing Ct.

Biotechnology

French Drugmaker Sanofi-Aventis SA Reaches Finall Agreement to Buy Genzyme Corp

Sanofi-Aventis SA has agreed in principle to acquire Genzyme Corp for $19.2 billion in cash

Novozymes to Buy EMD/Merck Crop BioScience

Amylopectin Starch Potatoes: Avebe and BASF Plant Science Cooperate

Spain Sets Out Plan To Boost Industry

Severin Schwan of Roche Sees Generic Companies and Innovators As Winners

Merck Set to Buy Biotech Firm SmartCells

Genmab CEO Worried By Takeover Risk

Genzyme, Sanofi at Odds Over Threshold Price

U.S. Proposes Wide Changes in Role Fighting Disease

White Knight Could Be Elusive For Genzyme

Genzyme Weighs Sanofi Approach, Not Keen to Sell

Building For Generations

BASF Plant Science, Monsanto to Expand Collaboration in Maximizing Crop Yield

Pharming Signs Manufacturing Deal with Sanofi-Aventis

Sanofi Declines Comment on U.S. Deal

Sanofi Buys TargeGen to Boost Cancer Treatments

Amgen CEO Looking for International Acquisitions

Merck to Seek 5 New Drug Approvals This Year

AstraZeneca Sees More Deals to Fill Out Pipeline

Amgen Promotes Bradway to CEO

Sanofi to Invest $200 Million in French Biotech Plants

'A Merger For Growth'

Is Merck KGaA's $6 Billion Bid for Millipore Too Costly?

Update: Merck KGaA Buys Millipore to Stabilize Business

Germany's Merck to Buy Millipore in $6 Billion Deal

Millipore Says Evaluating ‘Strategic Alternatives’

Thermo Fisher in $6 Billion Bid for Millipore

Linked Together

Biotech: A Major Contributor to  Pharma Global Business

Closing The Gap

Top-Feature

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Upcoming Virtual Events

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Siemens Joins the Global Impact Coalition

Virtual Event

Outsourced Biomanufacturing

Biotechnology

Top-Feature

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Upcoming Virtual Events

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Siemens Joins the Global Impact Coalition

Virtual Event

Newsletter & e-edition